ArticleAIDS research and therapy2021

Virologic outcomes of switching to dolutegravir functional mono- or dual therapy with a non-cytosine nucleoside analog: a retrospective study of treatment-experienced, patients living with HIV.

Charlotte-Paige Rolle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.